Mosaic ImmunoEngineering Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Mosaic ImmunoEngineering Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($165.4K) | Nov 19, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($172.0K) | Aug 19, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($181.3K) | May 20, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($186.7K) | Nov 19, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($293.7K) | Aug 19, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($288.5K) | May 20, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($333.2K) | Nov 19, 2024 |
| Q2 | 2024 | Jun 30, 2023 | $19.6K | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($399.0K) | May 14, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($153.7K) | Nov 2, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($929.6K) | Aug 3, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($763.5K) | May 12, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($1.05M) | Nov 1, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($979.4K) | Aug 4, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($806.8K) | May 10, 2022 |
| Q2 | 2021 | Nov 30, 2020 | ($631.0K) | Dec 29, 2020 |
| Q3 | 2021 | Sep 30, 2020 | ($386.5K) | Nov 2, 2021 |
| Q1 | 2021 | Aug 31, 2020 | ($115.9K) | Oct 15, 2020 |
| Q2 | 2021 | Jun 30, 2020 | ($40) | Aug 3, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($471) | May 5, 2021 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($144.4K) | Nov 19, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($148.9K) | Aug 19, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($174.8K) | May 20, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($186.4K) | Nov 19, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($274.3K) | Aug 19, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($268.8K) | May 20, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($311.9K) | Nov 19, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($352.5K) | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($459.8K) | May 14, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($517.2K) | Nov 2, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($883.7K) | Aug 3, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($729.0K) | May 12, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($961.1K) | Nov 1, 2022 |
| Q2 | 2012 | Nov 30, 2011 | ($781.3K) | Jan 17, 2012 |
| Q1 | 2012 | Aug 31, 2011 | ($805.2K) | Oct 17, 2011 |
| Q2 | 2012 | Nov 30, 2010 | ($1.74M) | Jan 17, 2012 |
| Q1 | 2012 | Aug 31, 2010 | ($1.58M) | Oct 17, 2011 |